PT1126853E - Distribuicao controlada de anti-depressivos - Google Patents
Distribuicao controlada de anti-depressivosInfo
- Publication number
- PT1126853E PT1126853E PT99971322T PT99971322T PT1126853E PT 1126853 E PT1126853 E PT 1126853E PT 99971322 T PT99971322 T PT 99971322T PT 99971322 T PT99971322 T PT 99971322T PT 1126853 E PT1126853 E PT 1126853E
- Authority
- PT
- Portugal
- Prior art keywords
- depressions
- controlled distribution
- triazolones
- antidepressants
- exemplified
- Prior art date
Links
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- -1 phenoxyethyl substituted-1, 2, 4-triazolones Chemical class 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10675898P | 1998-11-02 | 1998-11-02 | |
US10667798P | 1998-11-02 | 1998-11-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1126853E true PT1126853E (pt) | 2006-07-31 |
Family
ID=26803899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99971322T PT1126853E (pt) | 1998-11-02 | 1999-10-26 | Distribuicao controlada de anti-depressivos |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1126853B1 (pt) |
JP (1) | JP4711510B2 (pt) |
KR (2) | KR20070040421A (pt) |
AT (1) | ATE323493T1 (pt) |
AU (1) | AU1230800A (pt) |
CA (1) | CA2349719C (pt) |
CY (1) | CY1105463T1 (pt) |
DE (1) | DE69930952T2 (pt) |
DK (1) | DK1126853T3 (pt) |
ES (1) | ES2260962T3 (pt) |
HK (1) | HK1038515A1 (pt) |
PT (1) | PT1126853E (pt) |
WO (1) | WO2000025790A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1534238A1 (en) * | 2002-07-29 | 2005-06-01 | ALZA Corporation | Formulations and dosage forms for controlled delivery of topiramate |
US20050232995A1 (en) * | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
US20040092534A1 (en) * | 2002-07-29 | 2004-05-13 | Yam Nyomi V. | Methods and dosage forms for controlled delivery of paliperidone |
NZ546148A (en) | 2003-09-26 | 2009-05-31 | Alza Corp | Drug coating providing high drug loading and methods for providing the same |
US20070259033A1 (en) * | 2003-09-26 | 2007-11-08 | Evangeline Cruz | Controlled release formulations exhibiting an ascending rate of release |
CN101703488B (zh) * | 2008-12-16 | 2013-02-20 | 北京科信必成医药科技发展有限公司 | 具有润滑层结构的双层渗透泵控释片及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5082668A (en) * | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
US5116852A (en) * | 1990-12-03 | 1992-05-26 | Bristol-Myers Squibb Co. | Treatment of sleep disorders |
US5330762A (en) * | 1992-02-27 | 1994-07-19 | Alza Corporation | Tandospiaine antidepressive therapy |
ES2124910T3 (es) * | 1993-08-31 | 1999-02-16 | Alza Corp | Dispensador que contiene un agente hidrofobo. |
US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
CA2160423A1 (en) * | 1994-11-02 | 1996-05-03 | Hemant N. Joshi | Salts of nefazodone having improved dissolution rates |
US5990159A (en) * | 1996-02-15 | 1999-11-23 | Janssen Pharmaceutica, N.V. | Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
WO1997047285A1 (en) * | 1996-06-10 | 1997-12-18 | Depomed, Inc. | Gastric-retentive oral controlled drug delivery system with enhanced retention properties |
US6143325A (en) * | 1998-06-05 | 2000-11-07 | Bristol-Myers Squibb Company | Nefazodone dosage form |
-
1999
- 1999-10-26 DK DK99971322T patent/DK1126853T3/da active
- 1999-10-26 KR KR1020077006959A patent/KR20070040421A/ko not_active Application Discontinuation
- 1999-10-26 AU AU12308/00A patent/AU1230800A/en not_active Abandoned
- 1999-10-26 DE DE69930952T patent/DE69930952T2/de not_active Expired - Lifetime
- 1999-10-26 KR KR1020017005537A patent/KR100734193B1/ko active IP Right Grant
- 1999-10-26 EP EP99971322A patent/EP1126853B1/en not_active Expired - Lifetime
- 1999-10-26 CA CA002349719A patent/CA2349719C/en not_active Expired - Lifetime
- 1999-10-26 JP JP2000579231A patent/JP4711510B2/ja not_active Expired - Lifetime
- 1999-10-26 ES ES99971322T patent/ES2260962T3/es not_active Expired - Lifetime
- 1999-10-26 WO PCT/US1999/025017 patent/WO2000025790A1/en not_active Application Discontinuation
- 1999-10-26 PT PT99971322T patent/PT1126853E/pt unknown
- 1999-10-26 AT AT99971322T patent/ATE323493T1/de active
-
2002
- 2002-01-15 HK HK02100276A patent/HK1038515A1/xx not_active IP Right Cessation
-
2006
- 2006-07-07 CY CY20061100941T patent/CY1105463T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002528505A (ja) | 2002-09-03 |
DE69930952D1 (de) | 2006-05-24 |
KR20010075677A (ko) | 2001-08-09 |
KR100734193B1 (ko) | 2007-07-02 |
CA2349719C (en) | 2009-06-02 |
EP1126853B1 (en) | 2006-04-19 |
DK1126853T3 (da) | 2006-08-14 |
DE69930952T2 (de) | 2006-08-31 |
ES2260962T3 (es) | 2006-11-01 |
HK1038515A1 (en) | 2002-03-22 |
KR20070040421A (ko) | 2007-04-16 |
JP4711510B2 (ja) | 2011-06-29 |
WO2000025790A1 (en) | 2000-05-11 |
EP1126853A1 (en) | 2001-08-29 |
ATE323493T1 (de) | 2006-05-15 |
AU1230800A (en) | 2000-05-22 |
CA2349719A1 (en) | 2000-05-11 |
CY1105463T1 (el) | 2010-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199800077T1 (xx) | Kontroll� ��z�len paroksetin terkipleri. | |
BR0012908A (pt) | Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana | |
GB2387696A (en) | Real-time odds-based gaming | |
UA34466C2 (uk) | Засіб для несистемної боротьби з паразитуючими комахами | |
PT1459751E (pt) | (s,s)-reboxetina para tratar as enxaquecas | |
NZ333588A (en) | Sulphamates as anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS) | |
IL147803A0 (en) | 28-epirapalogs | |
ZA977695B (en) | 1,4-heterocyclic metalloprotease inhibitors. | |
IL138476A0 (en) | Method for treating pharmaceutical compositions by special use of anti-oxidant | |
ZA97927B (en) | New substituted oxazolidinones. | |
UA42795C2 (uk) | Протизапальний засіб для зовнішнього застосування, що містить німесулід, і спосіб його одержання | |
BR9703302A (pt) | Aparelho e método para a geração e uso de ìons férricos | |
AU1565300A (en) | Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol | |
ATE253351T1 (de) | Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane | |
MXPA00007394A (es) | Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas. | |
CY1105463T1 (el) | Ελεγχομενη χορηγηση αντικαταθλιπτικων | |
ZA978640B (en) | Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis. | |
GR3029294T3 (en) | Direct-acting hair colouring agent | |
ES2166045T3 (es) | Procedimiento para la preparacion de compuestos de 4,6-bis(ariloxi)pirimidina asimetricos. | |
MX9603516A (es) | Derivados de oxima y su uso como pesticidas. | |
UA32598C2 (uk) | Спосіб одержання лікарської форми карбамазепіну | |
ES2195405T3 (es) | Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion. | |
DK1459748T3 (da) | (S,S)-reboxetin til behandling af perifer neuropati | |
ZA200006978B (en) | Agents for controlling plant pests. | |
ZA200007071B (en) | Methods for regulating hematopoiesis using CPG-oligonucleotides. |